关注
Yesol Kim
Yesol Kim
在 wustl.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancer
D Son, Y Kim, S Lim, HG Kang, DH Kim, JW Park, W Cheong, HK Kong, ...
Cancer letters 454, 224-233, 2019
722019
Inhibition of S-adenosylhomocysteine hydrolase decreases cell mobility and cell proliferation through cell cycle arrest
SJ Park, HK Kong, YS Kim, YS Lee, JH Park
American journal of cancer research 5 (7), 2127, 2015
382015
Autophagy inhibits cancer stemness in triple‐negative breast cancer via miR‐181a‐mediated regulation of ATG5 and/or ATG2B
JW Park, Y Kim, S Lee, CW Oh, EJ Lee, JY Ko, JH Park
Molecular Oncology 16 (9), 1857-1875, 2022
342022
miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer
YS Kim, SJ Park, YS Lee, HK Kong, JH Park
Oncotarget 7 (27), 42261, 2016
322016
Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer
S Lim, Y Kim, SB Lee, HG Kang, DH Kim, JW Park, D Chung, H Kong, ...
Oncogenesis 9 (10), 91, 2020
262020
Epigenetic activation of LY6K predicts the presence of metastasis and poor prognosis in breast carcinoma
HK Kong, SJ Park, YS Kim, KM Kim, HW Lee, HG Kang, YM Woo, EY Park, ...
Oncotarget 7 (34), 55677, 2016
172016
Epigenetic upregulation of MAGE-A isoforms promotes breast cancer cell aggressiveness
C Oh, HR Kim, S Oh, JY Ko, Y Kim, K Kang, Y Yang, J Kim, JH Park, ...
Cancers 13 (13), 3176, 2021
152021
Reduced miR-371b-5p expression drives tumor progression via CSDE1/RAC1 regulation in triple-negative breast cancer
Y Kim, JY Ko, SB Lee, S Oh, JW Park, HG Kang, DH Kim, D Chung, S Lim, ...
Oncogene 41 (22), 3151-3161, 2022
122022
Transgenic overexpression of human LY6K in mice suppresses mature T cell development in the thymus
D Son, HK Kong, Y Kim, MJ Song, HP Kim, HW Lee, JH Park
Oncology Letters 17 (1), 379-387, 2019
42019
Hypomethylation of ATP1A1 Is Associated with Poor Prognosis and Cancer Progression in Triple-Negative Breast Cancer
Y Kim, JY Ko, HK Kong, M Lee, W Chung, S Lim, D Son, S Oh, JW Park, ...
Cancers 16 (9), 1666, 2024
12024
系统目前无法执行此操作,请稍后再试。
文章 1–10